Capitol Health Limited (ASX:CAJ) Scheme Becomes Effective
Scheme Details
Capitol Health Limited (ASX:CAJ) confirms that its scheme of arrangement with Integral Diagnostics Limited (ASX:IDX) is officially effective. This development follows the Federal Court’s approval and the lodging of the court orders with the Australian Securities and Investments Commission (ASIC). The Court’s orders facilitate the acquisition of all issued Capitol shares by IDX.
Trading Suspension
With the scheme now effective, Capitol shares will be suspended from trading on the ASX following the close of the trading session today. Shareholders can expect to receive payment on implementation, where they will receive 0.12849 IDX shares for each Capitol share held as of the Record Date, set for 7:00 PM AEDT on 13 December 2024.
Anticipated Timeline
The current implementation date is targeted for 20 December 2024, but dates may change. Capitol will provide updates on any adjustments through the ASX as needed. Shareholders with questions about their entitlements can reach out to the company or its Share Registry, Computershare.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.